AI | pharmaphorum

AI

Market Access

Encouraging early engagement to revitalise Europe’s pharmace...

In an on-site interview at Reuters Pharma Europe in Barcelona, this week’s podcast saw Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discuss revitalising Europe’

Digital

What pharma stands to gain from technological innovation

A growing number of patients and healthcare providers alike are focussing on preventative health and wellbeing measures, rather than relying on drugs alone as a post-diagnosis cure.

Digital

AI in Drug Discovery: Day Two

Back in the picturesque West End of London, even a sudden, torrential downpour could not dampen the spirits on 12th March as speakers and attendees returned once more to the Hilton Hotel in

Digital

Serena Goodwin and Jonah Comstock interview at Reuters Pharma USA

Reuters Pharma USA 2024 – Serena Goodwin

AI is changing workflows for all kinds of pharma stakeholders, including sales representatives and medical affairs liaisons.

Digital

navigating intellectual property challenges

Risk management strategies to navigate IP challenges associa...

Artificial intelligence (AI) is revolutionising industries. But with this exciting new frontier comes a complex challenge: protecting your intellectual property (IP).

Digital